- News & Views
- Published:
Cancer
Subjects
Two seminal studies report a bioengineering approach to modeling CAR-T cell therapy of solid human tumors.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout

References
-
Liu, H. et al. Nat. Biotechnol. https://doi.org/10.1038/s41587-025-02845-z (2025).
-
Maulana, T. I. et al. Cell Stem Cell 31, 989–1002.e9 (2024).
-
Huh, D. et al. Science 328, 1662–1668 (2010).
-
Khetani, S. R. & Bhatia, S. N. Nat. Biotechnol. 26, 120–126 (2008).
-
Ronaldson-Bouchard, K. et al. Nature 556, 239–243 (2018).
-
Ronaldson-Bouchard, K. et al. Nat. Biomed. Eng. 6, 351–371 (2022).
-
Sadelain, M., Rivière, I. & Riddell, S. Nature 545, 423–431 (2017).
-
June, C. H. & Sadelain, M. N. Engl. J. Med. 379, 64–73 (2018).
-
Hou, A. J., Chen, L. C. & Chen, Y. Y. Nat. Rev. Drug Discov. 20, 531–550 (2021).
-
Chen, N., Li, X., Chintala, N. K., Tano, Z. E. & Adusumilli, P. S. Curr. Opin. Immunol. 51, 103–110 (2018).
-
Albelda, S. M. Nat. Rev. Clin. Oncol. 21, 47–66 (2024).
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Vunjak-Novakovic, G. Tumor-on-chip models of CAR-T cell therapy. Nat Biotechnol (2025). https://doi.org/10.1038/s41587-025-02819-1
-
Published:
-
DOI: https://doi.org/10.1038/s41587-025-02819-1
